Drug · DIN 02445018
ABILIFY MAINTENA
SINGLE-USE PREFILLED DUAL CHAMBER SYRINGE CONTAINING A) POWDER AND B) DILUENT
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since August 20, 2015.
- Drug Identification Number (DIN)
- 02445018
- Company (DIN owner)
- Otsuka Pharmaceutical Co LtdChiyoda-Ku Tokyo, --, Japan
- Schedule
- Prescription
- Dosage form
- Powder For Suspension (Sustained-Release
- Route
- Intramuscular
- Therapeutic class (ATC)
- Aripiprazole N05AX12
- Class
- Human
- Record last updated
- September 21, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ARIPIPRAZOLE | 300 MG | SYR |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 20, 2015: NOC 17215Supplement to a New Drug Submission (SNDS) · New drig product container closure system
Other DINs named ABILIFY MAINTENA
- DIN 02420864 · Marketed
- DIN 02420872 · Marketed
- DIN 02445026 · Approved